StemCyte International, Ltd. (TPEX:4178)
25.65
+1.35 (5.56%)
At close: Apr 28, 2026
StemCyte International Revenue
In the year 2025, StemCyte International had annual revenue of 368.91M TWD, down -3.60%. StemCyte International had revenue of 87.21M in the quarter ending December 31, 2025, a decrease of -15.67%.
Revenue
368.91M
Revenue Growth
-3.60%
P/S Ratio
13.38
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.94B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ARBOR Technology | 2.03B |
| UNIC Technology | 4.85B |
| Fabulous Global Holding | 3.78B |
| Promate Solutions | 2.08B |
| United Fiber Optic Communication | 1.35B |
| Spectrum Electrics | 2.20B |
| Fong-Chien Construction Co.,LTD. | 5.25M |
| Tachan Securities | 227.32M |